I'm on the lookout for a co-founder to apply to YC with a de-risked idea set to change the landscape of psychiatry treatment through AI. Here’s what we’re tackling:
The Issue: Accurate diagnosis of Major Depressive Disorder (MDD) is just the beginning; the real challenge lies in identifying its biological subtypes which dictate treatment strategies. Currently, there’s no reliable method to detect these subtypes, making treatment a hit-or-miss scenario.
Our Solution: We’re developing an AI platform that uses EEG data and ML models to predict the most effective TMS treatments for MDD and potentially other diseases.
Market Potential: There are 17 million MDD patients in need, plus countless others suffering from conditions that could benefit from better TMS treatment strategies.
Our Team: I am an ex-founder of a VC-backed AI startup and have worked at companies like Microsoft and EY. My partner, as a researcher and ex-engineer at MediaTek, has successfully developed similar models, implemented in a major medical center in Asia, and is now eager to adapt this experience to the U.S. market.
Why You Should Join: You'd be part of a venture that's not only technically validated but also has shown commercial promise.
We need a co-founder who is as passionate about improving mental health as we are, with strong ties in the healthcare industry and experience in sales & BD or psychiatric research.
Interested? Shoot me an email at aidan.new.venture@gmail.com with details about something impressive you've built, why you think you'd be a great fit, and your whatsapp.
Join us to make a real difference in mental health care.
TMS has a lot of side effects (Seizures, cognitive effects, permanent increases in auditory threshold, tinnitus, headaches) and the overall neurological mechanisms are not, to my knowledge, well known - my interpretation is that its a bit like degaussing a brain. If you have secret sauce, its in studies that aren't public. Assuming its based around studies like this: https://www.sciencedirect.com/science/article/abs/pii/S01651...
Is it a viable GTM strategy? Maybe - but you may find yourself having every incentive to hype up a procedure that may cause harm, even if legal, which seems like an ethical minefield if not a significant source of liability. If the effects of TMS across the whole nervous system were more well known and side effects could be more easily predicted, perhaps that would be another story.
There are so mamy people that think depression is just a chemical imbalance that can be solved by treatments and ignore the fact that many times there is a legitimate cause for their valid feelings.
While acknowledging the side effects of TMS, including those you've mentioned like cognitive effects and headaches, our research focuses on mitigating these through targeted treatment approaches. Severe side effects are relatively rare, and our goal is to further reduce their likelihood through improved predictive accuracy.
Meanwhile you might want to take a look at our research: https://www.sciencedirect.com/science/article/abs/pii/S01650...